IDNA — IDNA Genomics Public Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for IDNA Genomics Public, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—
Source:	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.128	0.116	0.105
Net Total Accounts Receivable
Net Total Receivables	1	0.329	0.349
Total Inventory
Total Current Assets	1.3	0.6	0.664
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.91	0.772	0.417
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4.01	7.17	7.52
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.764	1.13	2.29
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	3.74	3.4	5.12
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.276	3.76	2.4
Total Liabilities & Shareholders' Equity	4.01	7.17	7.52
Total Common Shares Outstanding